REM and Deep Sleep Linked to Lower Disease Risk in Large Study

Analysis Links Sleep Architecture to Over 80 Health Conditions

Higher amounts of rapid eye movement (REM) sleep and deep sleep link to lower rates of multiple chronic illnesses. Researchers analyzed accelerometer data from 95,559 participants in the United Kingdom (UK) Biobank cohort. Participants wore wrist monitors for seven consecutive days.

A deep-learning model classified sleep stages across the cohort. Investigators followed these adults for a median of 8.9 years. The team evaluated health records across more than 1,000 disease outcomes, finding 156 significant associations after statistical correction.

Deep Sleep Associates with Lower Type 2 Diabetes Incidence

Time spent in slow-wave deep sleep correlates with a lower incidence of type 2 diabetes and major depressive disorder. Deep sleep totals correlated with lower risk across seven conditions. Metabolic regulation often relies on these deeper stages.

Rapid eye movement sleep connected to a broader set of 83 conditions. Each 47.6-minute increase in REM sleep corresponded to lower risk for specific neurological and cardiovascular diseases. Observed hazard ratios reached 0.74 for heart failure, 0.54 for dementia, and 0.20 for Parkinson's disease.

A Six to Eight Hour Window Concentrates the Lowest Disease Rates

Total sleep duration between six and eight hours aligns with the lowest disease risk across 69 distinct conditions. Sleeping under five hours correlated with higher risk across 37 conditions. The relationship remained nonlinear.

Disruptions during the night also tracked with poor long-term psychological health. Wakefulness after sleep onset and schedule irregularity both correlated with higher rates of anxiety. Night-to-night consistency supported better overall sleep patterns.

Observational Evidence Leaves Causality Unresolved

The UK Biobank dataset remains observational and does not establish that sleep stages directly prevent disease. Unmeasured habits or early disease could alter sleep architecture years before diagnosis. Talk to a clinician about personal sleep patterns.

The cohort focused on middle-aged and older adults in the UK Biobank. Wearable accelerometers improve upon self-reported surveys, but clinical trials must test whether improving sleep stages alters metabolic outcomes. Consistent bedtimes help stabilize nocturnal rest.